Cite
HARVARD Citation
Fonseca, T. et al. (2013). The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2 in Spain. Journal of medical economics. pp. 926-938. [Online].